Wear of the inlay in total knee arthroplasty (TKA) contributes to implant failure and the need for revision surgery. In vivo wear assessment is challenging owing to the radiolucency of the inlay in standard radiographs. This study aimed to investigate the basic feasibility of integrating radiopaque X-ray markers on standard inlays to enhance their radiographic visibility and enable wear evaluation.

Preliminary experiments identified optimal process parameters for micro-milling cavities on ultra-high molecular weight polyethylene (UHMWPE). A total of 450 parameter combinations were evaluated, with burr formation serving as the quality criterion. A process chain, comprising pre-contouring, micro-milling, filling cavities with radiopaque composite, and final contouring, was developed for inlay production. Eleven inlays with varying marker alignments, orientations, and geometries were manufactured, featuring grooves (≤0.8 mm wide) and holes (diameter = 1.6 mm), both 1 mm deep. Three HDPE + BaSO₄ composites (10, 20, and 30 wt.% BaSO₄) were formulated and assessed for radiopacity per ASTM F640-20. Final marker cavities were filled with HDPE + 20 wt.% BaSO₄ via pellet extrusion. The inlays were positioned in a phantom knee setup and radiographed in the anteroposterior view. Projected markers were evaluated based on edge visibility, measurability, homogeneity, and obscuration by the implant.

None of the parameter combinations resulted in burr-free cavities, indicating an unstable five-axis process. X-ray images revealed that grooves aligned in the X-ray direction and drilled holes exhibited the best visibility for wear markers. Pin-on-plate tribological experiments revealed that BaSO₄ addition to pure HDPE reduced its CoF from 0.25 to 0.1, reaching a value comparable to UHMWPE (0.15), while also enhancing wear resistance.

This study demonstrated the feasibility of integrating wear markers on standard TKA inlays by micro-milling cavities at different positions and orientations on the inlay surface and filling them with a radiopaque composite. Further research is required to optimise process parameters and investigate marker wear.

The authors have declared no competing interest.

This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB/TRR-298-SIIRI Project-ID 426335750.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes